Federal Supply Schedule 36F79725D0044
Award Date
1/15/25
Last Date to Order
1/14/30
Federal Agency
Veterans Integrated Service Network 12
Awardee
GC Biopharma Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12, a civilian federal agency, to GC Biopharma USA, Inc. The contract has a ceiling value of $25,000.00 and a period of performance through January 14, 2025. The FSS contract is for the procurement of drugs, pharmaceuticals, and hematology related products under Schedule 65 IB. Additionally, a Blanket Purchase Agreement (BPA) was awarded under this FSS contract with a ceiling value of...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) to Genus Lifesciences Inc. The contract has a ceiling value of $225,000.00 and a period of performance from October 1, 2018 to September 30, 2026. The contract is intended to procure drugs, pharmaceuticals, and hematology-related products for VISN 12, which is a civilian federal agency within...
This Federal Supply Schedule contract, awarded by the U.S. Department of Veterans Affairs to Genmab US Inc., is for the procurement of drugs, pharmaceuticals, and hematology-related products (FSC 65 I B). The contract has a ceiling value of $750,000.00 and a period of performance from November 15, 2023, to November 14, 2028. The contract was awarded on a multiple-award basis and does not utilize any set-asides. As a Federal Supply Schedule contract, it provides a streamlined procurement...
This Federal Supply Schedule (FSS) contract was awarded by the U.S. Department of Veterans Affairs (VA) to G1 Therapeutics, Inc. for the provision of pharmaceutical and drug products. The contract has a ceiling value of $2,250,000.00 and a period of performance through July 14, 2026. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and allows for the delivery of a broad range of drug and hematology-related products to the VA and its related healthcare...
This Federal Supply Schedule contract with the Department of Veterans Affairs (VA) is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Biocon Biologics Inc., a foreign-owned for-profit manufacturer of goods. The contract has a ceiling value of $750,000.00 and a period of performance from March 1, 2024 to February 28, 2029. As a Federal Supply Schedule contract, this is a multiple award, indefinite delivery vehicle that allows federal...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract (36F79722D0202) awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 12 to CTI Biopharma Corp. (doing business as CTI Biopharma), a for-profit manufacturer of drugs, pharmaceuticals, and hematology-related products. The multiple-award contract has a ceiling value of $3,000,000 and an ultimate completion date of October 31, 2027. This FSS contract under...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract, specifically under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract was awarded to Almirall, LLC, a foreign-owned, for-profit manufacturer of goods. The contract has a ceiling value of $5,500,000.00 and a period of performance through May 15, 2025. The contract is intended to procure drugs, pharmaceuticals, and hematology-related products for the Veterans Integrated Service Network 12 (VISN 12),...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to United Guardian Inc. and its Guardian Laboratories division. The contract, with a ceiling value of $4,732,440.00, is for the delivery of pharmaceutical and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. The contract has a period of performance through July 31, 2030, and was awarded on August 1, 2020. United Guardian...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB for Drugs, Pharmaceuticals, and Hematology Related Products. The contracting agency is the Department of Veterans Affairs (VA), specifically Veterans Integrated Service Network 12. The prime contractor is Alpha Cognition USA, Inc., a for-profit manufacturer. The contract has a ceiling value of $25,000.00 and a period of performance through September 30, 2025. It is a multiple award IDV, meaning...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to BeiGene USA, Inc., provides for the procurement of pharmaceutical and hematology-related products. The contract has a ceiling value of $700,000.00 and a period of performance through July 31, 2025. The FSS contract, part of the Pharmaceuticals and Drugs (FSS-61-IB) schedule, enables the VA to order a variety of pharmaceutical and hematology products from the contractor as needed. As a multiple...